483
Shionogi Pharma Co., Ltd.Shionogi Pharma Co., Ltd. – FDA 483, May 30, 2025
Record Details
Shionogi Pharma Co. Ltd. in Seitsu, Osaka, Japan, was cited for three observations during an FDA inspection. The firm failed to thoroughly review unexplained discrepancies, particularly regarding foreign matter in drug product batches. Additionally, the written stability program was inadequate, not ensuring drug products are tested in their marketed container-closure systems, and procedures for testing incoming components lacked sufficient detail to prevent foreign matter contamination.
View Company Profile
ID · 833daad8-0cfb-4648-9bda-947515be328d
Other documents for Shionogi Pharma Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.